SCHEMBL16100491

SCHEMBL16100491

CN(C)CC=CC(=O)N1CCN(C(=O)c2cc(-c3ccccc3Cl)c(Cl)cc2O)CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HSP90AA1 P07900 6/20 0.42
▸ CDK14 O94921 1/20 0.40
▸ CCNY Q8ND76 1/20 0.40
▸ EGFR P00533 3/20 0.40
▸ BTK Q06187 3/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ F2R P25116 1/20 0.38
▸ TXK P42681 1/20 0.37
▸ ITK Q08881 1/20 0.37
▸ JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16100490 1.00 MAPT (0.42) MAPTL3MBTL1HSP90AA1CDK14CCNY
SCHEMBL16102029 0.87 TXK (0.48) MAPTL3MBTL1BTKRAB9AALOX15
SCHEMBL16102030 0.87 TXK (0.48) MAPTL3MBTL1BTKRAB9AALOX15
SCHEMBL17608793 0.83 MAPT (0.41) MAPTL3MBTL1CDK14CCNYEGFR
SCHEMBL17608791 0.83 MAPT (0.41) MAPTL3MBTL1CDK14CCNYEGFR
SCHEMBL31672355 0.83 MAPT (0.41) MAPTL3MBTL1CDK14CCNYEGFR
SCHEMBL16101856 0.82 HSP90AA1 (0.48) HSP90AA1RAB9ALMNATP53ALOX15
SCHEMBL17643350 0.79 BLM (0.49) HSP90AA1RAB9ALMNATP53ALOX15
SCHEMBL17800783 0.79 BTK (0.40) MAPTL3MBTL1CDK14CCNYEGFR
SCHEMBL31672378 0.79 BTK (0.40) MAPTL3MBTL1CDK14CCNYEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970121-A1 COVALENT INHIBITORS OF KRAS G12C Araxes Pharma LLC (US) 2016-01-20 — — EP disclosed
WO-2014152588-A1 COVALENT INHIBITORS OF KRAS G12C ARAXES PHARMA LLC (US) 2014-09-25 — — WO disclosed
Send feedback